1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
August 6, 2026. PAR-24-174. Policy change: no non-U.S. subawards under parent grant per NOT-OD-25-104.
Global Infectious Disease Research Training Program is sponsored by Fogarty International Center at NIH. Global Infectious Disease Research Training Program is a grant from the Fogarty International Center at NIH that funds research training programs focused on infectious diseases predominantly endemic in or significantly impacting people in low- and middle-income countries (LMICs).
Get alerted about grants like this
Get emailed when new opportunities from “Fogarty International Center at NIH” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Global Infectious Disease Research Training (D43 D71) - Fogarty International Center @ NIH Global Infectious Disease Research Training NIH’s policy on non-U.S. subawards has changed . NIH is establishing a new award structure that will prohibit foreign subawards from being nested under the parent grant. Until this policy is in place, NIH will not issue awards to domestic or foreign entities that include a subaward to a foreign entity.
Applications with non-U.S. subawards will not be accepted by NIH for review and will be automatically withdrawn. Applicants are advised not to use non-U.S. subawards.
Global Infectious Disease Research Training Program ( D43 Clinical Trial Optional) (PAR-24-174) Country eligibility for Fogarty international training grants Applicant institutions may submit more than one application, provided that each application is scientifically distinct. U.S. institutions with a demonstrated collaboration with a researcher at a LMIC institution may apply. Foreign institutions in LMICs may also apply.
Applicant institution must have robust and high-quality research ongoing in the areas proposed. D43 Eligibility Information for more details. Global Infectious Disease (GID) research training program addresses research training needs related to infectious diseases that are predominantly endemic in or impact upon people living in developing countries.
The training programs include a variety of research training options to match the needs of the developing country institution. Program focus on a major endemic or life-threatening emerging infectious disease, neglected tropical disease, infections that frequently occur as a co-infection in HIV infected individuals, or infections associated with noncommunicable disease conditions of public health importance in LMICs.
The ultimate goal is to build a critical mass of researchers and support staff to conduct independent infectious disease research in developing country institutions.
Training programs may include: Long-term (master's or doctoral degree and other training that is six months or longer) training for the full range of skills necessary to support research and research administration with the understanding that the focus of thesis and training-related research will be in their country.
Medium-term (three- to up to six-months) training or mentoring, including specialized clinical, laboratory, research or administrative/business skills necessary to support research that is planned or ongoing.
Short-term (less than three months) training or mentoring that focuses on research methodology, laboratory skills necessary to support research ethics and compliance issues, program and grants administration and financial management, grant writing, preparation of scientific manuscripts, data management, informatics, and other relevant areas.
Institutional capacity-building efforts such as in-country training workshops in advanced research techniques, distance learning and informatics. Advanced in-country mentored research undertaken by the trainee in their home country upon completion of his/her initial period of long-term training under the program.
Starting with 2019 application deadlines, D71 planning grants are eligible for up to two years of support, with increased funds for training resources, including faculty strengthening activities; development of advanced course and training resources; and training program evaluation. View a full list of Global Infectious Diseases (GID) Research Training grant awards by institution.
Division of International Training and Research Fogarty International Center National Institutes of Health 31 Center Drive, MSC 2220 Telephone: (301) 402-9467 Grants Management Specialist Fogarty International Center 31 Center Drive, MSC 2220 Satabdi. Raychowdhury@nih. gov The D43 announcement is issued by Fogarty in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) .
Nutritional research in Tanzania may help coal miners in the U.S. Global Health Matters , July/August 2025 This infectious disease expert helped build Uganda’s research infrastructure Global Health Matters , September/October 2023 Peru’s research infrastructure, supported by Fogarty, continues to blossom Global Health Matters , July/August 2023 UB, partners receive $1.
5 million NIH grant for infectious disease training program University of Buffalo news, April 11, 2023 Fogarty Grant Recipient & Trainee Publications Risk of arboviral transmission and insecticide resistance status of Aedes mosquitoes during a yellow fever outbreak in Ghana , co-authored by Fogarty grant recipient Yaw Asare Afrane BMC Infectious Diseases , July 25, 2025 Prognostics of multiple malaria episodes and nutritional status in children aged 6 to 59 months from 2013 to 2017 in Dangassa, Koulikoro region, Mali , co-authored by Fogarty grant recipient Seydou Doumbia and Fogarty trainees Soumba Keita, Mahamoudou Toure, Daouda Sanogo and Mahamadou Diakite Malaria Journal , June 13, 2024 Seroprevalence of Human T-Cell Lymphotropic Virus-1 in a Jamaican Antenatal Population and Assessment of Pooled Testing as a Cost Reduction Strategy for Implementation of Routine Antenatal Screening , co-authored by Fogarty trainees Ynolde Leys, Tiffany Butterfield, and Jacynth Moore The American Journal of Tropical Medicine and Hygiene , October 23, 2023 Resurgence of Malaria Transmission and Incidence after Withdrawal of Indoor Residual Spraying in the District of Koulikoro, Mali , co-authored by Fogarty grant recipient Seydou Doumbia and Fogarty trainees Mahamoudou Touré, Drissa Konaté, Mahamadou Diakité, and John Beier The American Journal of Tropical Medicine and Hygiene , September 6, 2023 Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh , co-authored by Fogarty grantees Stephen Calderwood, Firdausi Qadri, and Edward Ryan, and Fogarty trainees Mohammad Kamruzzaman and Richelle Charles mSphere , August 30, 2023 Amblyomma cajennense and Rhipicephalus microplus ticks collected in Colombia , co-authored by Fogarty grant recipients Patricia Aguilar and Juan Rodas, and Fogarty trainee Francisco Díaz Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants , co-authored by Fogarty grant recipients Edward T.
Ryan and Firdausi Qadri mSphere , February 23, 2024 Association of severe malaria with cognitive and behavioural outcomes in low- and middle-income countries: a meta-analysis and systematic review , co-authored by Fogarty Advisory Board member Chandy John Malaria Journal , August 3, 2023 Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) (PAR-21-120) Grants awarded through PAR-21-120 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71 Clinical Trials Not Allowed) (PAR-19-362) Grants awarded through PAR-19-362 in NIH RePORTER Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) (PAR-20-229) Grants awarded through PAR-20-229 in NIH RePORTER Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) (PAR-18-840) Grants awarded through PAR-18-840 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-17-058) Grants awarded through PAR-17-058 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-15-160) Grants awarded through PAR-15-160 in NIH RePORTER Global Infectious Disease Research Training Program (D43) (PAR-14-193) Grants awarded through PAR-14-193 in NIH RePORTER Global Infectious Disease Research Training Program (D71) (PAR-14-194) Grants awarded through PAR-14-194 in NIH RePORTER Global Infectious Disease Research Training Program (D43) (PAR-10-260) Grants awarded through PAR-10-260 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-10-262) Grants awarded through PAR-10-262 in NIH RePORTER Global Infectious Disease Research Training Program Award (D43) (PAR-08-154) Grants awarded through PAR-08-154 in NIH RePORTER Global Infectious Disease Research Training Program Award (D43) (PAR-05-128) Grants awarded through PAR-05-128 in NIH RePORTER Global Infectious Disease Research Training Program Award (D43) (PA-03-012) Grants awarded through PA-03-012 in NIH RePORTER
According to the current listing, eligibility includes: U. S. institutions with demonstrated collaboration with LMIC researcher may apply. Foreign institutions in LMICs may also apply. Note: Per NOT-OD-25-104, applications with non-U. Confirm the full requirements in the official notice before applying.
The current listing shows $230,000/year direct costs for new awards; $276,000/year for renewals; max 5 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The most recent published deadline was August 6, 2026, which has passed. This is an annual program, so a new cycle should follow. Check the funder's website for the next application window.
Global Infectious Disease Research Training Program is funded by Fogarty International Center at NIH. Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.
As of October 1, 2025, NIH no longer posts Notices of Funding Opportunity in the NIH Guide — Grants.gov is now the single official source (NOT-OD-25-143). The weekly Guide table-of-contents email that thousands of investigators relied on to discover funding no longer lists opportunities. Combined with the January 25, 2026 SciENcv certified-PDF requirement, the mechanics of finding and applying for NIH money have changed underneath everyone. Here is how to rebuild your discovery workflow so nothing slips through.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleThe NIH Director's New Innovator Award (DP2, RFA-RM-27-002) closes August 17, 2026, offering roughly 30 Early Stage Investigators up to $475,000 in direct costs a year for five years — $2.375 million total — to pursue bold ideas without the preliminary data a standard R01 demands. Here is how the High-Risk, High-Reward program actually evaluates applications, who qualifies, and why the usual R01 instincts will sink you.
Read article